Lexaria Bioscience (LEXX) Stock Statistics & Valuation Metrics

Lexaria Bioscience has a market cap or net worth of $19.01M. The enterprise value is $10.24M.

Lexaria Bioscience has 24,887,445 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lexaria Bioscience’s return on equity (ROE) is -3.98 and return on invested capital (ROIC) is -428.95%.

The current PE Ratio of Lexaria Bioscience is ―. Lexaria Bioscience’s PEG ratio is -0.03.

In the last 12 months, Lexaria Bioscience had revenue of 705.92K and earned -11.90M in profits. Earnings per share was -0.66.

In the last 12 months, operating cash flow was -8.71M and capital expenditures 3.00, giving a free cash flow of -8.71M billion.

Lexaria Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Lexaria Bioscience upcoming earnings date is ―, ―.

Lexaria Bioscience as a current ratio of 2.32, with Debt / Equity ratio of 2.07%

In the past 12 months, Lexaria Bioscience has paid 0.00 in taxes.

Lexaria Bioscience EV to EBITDA ratio is -1.20, with an EV/FCF ratio of -1.35.

Lexaria Bioscience has $4.42M in cash and marketable securities with $101.92K in debt, giving a net cash position of $4.32M billion.

Gross margin is 84.90%, with operating margin of -1647.97%, and net profit margin of -1686.00%.

The average price target for Lexaria Bioscience is $1.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy